MedPath

To study the effect of Panchvalkal lep in management of Vranashoth (Inflammation of subcutaneous tissue)

Phase 2
Conditions
Health Condition 1: L039- Cellulitis and acute lymphangitis,unspecified
Registration Number
CTRI/2022/07/044111
Lead Sponsor
siddharth dattatray gite
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group- Patients between age group 20 to 60 yrs.

Irrespective of Gender,Cast, religion, occupation.

Patient having lakshanas of vranashotha in ama and pachyamana avastha.

Localized Subcutenous Traumatic edema

Vranashotha less than 20 cm

Patient who gives voluntary consent for study

Exclusion Criteria

Patients having known history of HIV,DM, Hepatitis B, IHD, TB, gout, RA, Acute limb ischemia, liver diseases, renal failure, cardiac condition, malignancy etc.

Patient having Vranashotha in pakva avastha.

Patient presenting with DVT, fracture.

Pregnant woman.

Vranshotha with complication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesment of inflamation after treatmentTimepoint: one and half month
Secondary Outcome Measures
NameTimeMethod
Assesment will be done when the inflammation will be reduced and swelling will reduce to normalTimepoint: One and half month
© Copyright 2025. All Rights Reserved by MedPath